Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis.
about
Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brainEpstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causationEnvironmental risk factors for multiple sclerosis: a review with a focus on molecular mechanismsEpstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapyDecreased CD8+ T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes.Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosisAnti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel.Dysregulated Epstein-Barr virus infection in the multiple sclerosis brainDecreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis.Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models.Is the risk of multiple sclerosis related to the 'biography' of the immune system?Current understanding on the role of standard and immunoproteasomes in inflammatory/immunological pathways of multiple sclerosis.99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Epstein-Barr virus and multiple sclerosis: epidemiological evidence.Epstein-Barr virus in the multiple sclerosis brain: a controversial issue--report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria.Multiple sclerosis and environmental factors: the role of vitamin D, parasites, and Epstein-Barr virus infection.Phenotypic and functional characterization of T cells in white matter lesions of multiple sclerosis patients.The Ankylosing Spondylitis-associated HLA-B*2705 presents a B*0702-restricted EBV epitope and sustains the clonal amplification of cytotoxic T cells in patients.Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis.Multiple sclerosis: are protective immune mechanisms compromised by a complex infectious background?Epstein-Barr virus and disease activity in multiple sclerosis.Higher incidence of Epstein-Barr virus-induced lymphocyte transformation in multiple sclerosis.Radioactive in situ hybridization for Epstein-Barr virus-encoded small RNA supports presence of Epstein-Barr virus in the multiple sclerosis brain.B-cell enrichment and Epstein-Barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosis.Epstein-Barr virus and multiple sclerosis: causation or association?Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells.Mice expressing human ERAP1 variants associated with ankylosing spondylitis have altered T-cell repertoires and NK cell functions, as well as increased in utero and perinatal mortality.Human leucocyte antigen (HLA) class I and II typing in Belgian multiple sclerosis patients.Cytomegalovirus and multiple sclerosis risk.Selective association of multiple sclerosis with infectious mononucleosis.HLA alleles modulate EBV viral load in multiple sclerosis.
P2860
Q24642187-14296BA3-833E-4A70-9878-670821701F66Q26830464-2DBD44B8-95AC-4B99-B14B-24C831ED2103Q27006548-64B0826D-1BAA-4F31-9761-2AEB52C8FD0CQ30878158-8CBAEC93-C7E0-41F2-9C54-C7065AE7CB20Q33979100-B2D1AD59-39B8-476B-9CDA-832CACC5A6F7Q34671815-968359C8-5267-4BA5-A8FA-A67BB8937CCFQ35231431-4913FA22-3348-4E49-8E1C-5E774A28BE01Q36229219-E4CF07FE-34AD-4351-823D-5BFD4C0E66FDQ37145510-A55C9296-7403-43C3-8C95-866D31F3FF64Q37313736-6B8DEA2D-8082-4FFB-9EC3-83F13F6DEE95Q37404522-DCF7CEFA-5A30-4C87-BD95-6B194C22529FQ37541906-EB71EF12-DF78-420B-9410-1D509A95AAD5Q37736591-0A9F5689-2B1A-457F-A83E-5B60F25DF908Q38366750-FE359D0C-C09B-41EE-9C4F-9F27C4080F52Q38517180-7F02D79F-CA0D-4915-9537-42EC108A42E9Q38720773-4A4B0E1D-2C58-41A8-8BFD-81130E32CA93Q39715318-223EE104-A159-4D50-80BB-375080013598Q40333194-45A097D2-349A-441D-A4B3-36228CE86079Q41486516-14D68BBB-72D0-40EE-A67C-7AFEE3703D97Q41761640-ED053198-F293-44A9-98B1-40A6977DB8B6Q42227948-036AE5B4-3110-4F5A-8546-A2D59EF3A40BQ45352914-66715689-D08F-48A3-9634-E89D8A944A99Q45353475-E557A837-A512-42B9-AFC4-6CF426B7C704Q45370778-1FAB8CB0-47AB-4CF6-B487-C48A7050E4FDQ47546882-9EE20469-372C-4640-8F9D-ED3DE30AB906Q47666252-F01FAD24-88AE-4506-8FDB-403BD7465E04Q48262357-03DB47CF-5E29-4AA5-975F-2998A9F1C04EQ51878037-CDEF7C1B-3368-4215-AF98-0D0FB7796D78Q53032719-86155E41-79DF-4FB6-83B4-6A65DC968C8AQ55017154-B269484F-C457-4708-8FF0-DD57F7770107
P2860
Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Altered CD8+ T cell responses ...... ients with multiple sclerosis.
@en
Altered CD8+ T cell responses ...... ients with multiple sclerosis.
@nl
type
label
Altered CD8+ T cell responses ...... ients with multiple sclerosis.
@en
Altered CD8+ T cell responses ...... ients with multiple sclerosis.
@nl
prefLabel
Altered CD8+ T cell responses ...... ients with multiple sclerosis.
@en
Altered CD8+ T cell responses ...... ients with multiple sclerosis.
@nl
P2093
P2860
P921
P1476
Altered CD8+ T cell responses ...... ients with multiple sclerosis.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2249.2003.02114.X
P577
2003-04-01T00:00:00Z